Antares Pharma, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Antares Pharma, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Antares Pharma, Inc.. The Group's principal activity is developing drug delivery transdermal and transmucosal pharmaceutical products and drug delivery injection devices and supplies. The Groups product includes Advanced Transdermal Delivery gels, fast-melt oral tablets, disposable mini-needle injection systems and reusable needle-free injection systems. The ATD gel product is an Anturol oxybutynin for the treatment of overactive bladder. The Groups gels are hydro-alcoholic and contain a combination of permeation enhancers to promote rapid drug absorption through the skin. The Easy Tec fast-melt oral disintegrating tablets are designed to help patients who experience difficulty swallowing pills, tablets or capsules. It has also developed variations of the jet injector by adding a very small hidden needle to a pre-filled, single-use disposable injector, called the Vibex mini-needle injection system. The Group operates in the United States, Europe and Switzerland.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report